Anti-adhesion therapies and the rule of 3 for rare events.
about
Patient considerations in the management of ulcerative colitis - role of vedolizumabNew strategies for treatment of inflammatory bowel diseaseComment on 'anti-adhesion therapies and the rule of 3 for rare events'.GPR4 deficiency alleviates intestinal inflammation in a mouse model of acute experimental colitis.
P2860
Anti-adhesion therapies and the rule of 3 for rare events.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Anti-adhesion therapies and the rule of 3 for rare events.
@en
type
label
Anti-adhesion therapies and the rule of 3 for rare events.
@en
prefLabel
Anti-adhesion therapies and the rule of 3 for rare events.
@en
P2093
P2860
P356
P1476
Anti-adhesion therapies and the rule of 3 for rare events.
@en
P2093
Akbar K Waljee
Peter D R Higgins
Shail M Govani
P2860
P304
P356
10.1038/AJG.2013.141
P407
P577
2013-12-01T00:00:00Z